Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
about
Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adultsKetamine and other glutamate receptor modulators for depression in bipolar disorder in adultsKetamine and other glutamate receptor modulators for depression in adultsPractical application of the neuroregenerative properties of ketamine: real world treatment experienceBeyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive ReviewRemission From Behavioral Dysregulation in a Child With PTSD After Receiving Procedural KetamineA brief history of the development of antidepressant drugs: from monoamines to glutamateIncreased Signaling via Adenosine A1 Receptors, Sleep Deprivation, Imipramine, and Ketamine Inhibit Depressive-like Behavior via Induction of Homer1a.A Clickable Analogue of Ketamine Retains NMDA Receptor Activity, Psychoactivity, and Accumulates in Neurons.A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice.The Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition.Adult neurogenesis and mental illness.The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stressSo you think you can jump? A novel long jump assessment to detect deficits in stroked mice.NMDA Receptors Regulate the Structural Plasticity of Spines and Axonal Boutons in Hippocampal Interneurons.New frontiers in the neuropsychopharmacology of mental illness.Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder.Profiling of Proteins Regulated by Venlafaxine during Neural Differentiation of Human CellsEnhanced dopamine-dependent hippocampal plasticity after single MK-801 application.GPR39 (zinc receptor) knockout mice exhibit depression-like behavior and CREB/BDNF down-regulation in the hippocampusUse of ketamine in acute cases of suicidalityRodent models of treatment-resistant depression.NTRK2 expression levels are reduced in laser captured pyramidal neurons from the anterior cingulate cortex in males with autism spectrum disorder.Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice.The effect of imipramine, ketamine, and zinc in the mouse model of depressionNovel Glutamatergic Treatments for Severe Mood Disorders.Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents.New Hippocampal Neurons Mature Rapidly in Response to Ketamine But Are Not Required for Its Acute Antidepressant Effects on Neophagia in Rats.Food-derived hydrophilic antioxidant ergothioneine is distributed to the brain and exerts antidepressant effect in mice.Sodium ferulate and n-butylidenephthalate combined with bone marrow stromal cells (BMSCs) improve the therapeutic effects of angiogenesis and neurogenesis after rat focal cerebral ischemiaThe interactive effects of ketamine and magnesium upon depressive-like pathology.Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters.Common mechanisms of pain and depression: are antidepressants also analgesics?Pregnanolone Glutamate, a Novel Use-Dependent NMDA Receptor Inhibitor, Exerts Antidepressant-Like Properties in Animal Models.Fresh approaches to antidepressant drug discovery.Drugs currently in Phase II clinical trials for cocaine addiction.Sex-dependent effects of stress on immobility behavior and VTA dopamine neuron activity: modulation by ketamine.Microtubule and microtubule associated protein anomalies in psychiatric disease.Rapid Resolution of Grief with IV Infusion of Ketamine: A Unique Phenomenological Experience.Prediction of individual differences in fear response by novelty seeking, and disruption of contextual fear memory reconsolidation by ketamine
P2860
Q22252957-6A10357F-43AA-4619-B36B-C264E264DB53Q24186726-D4083E6A-D9B2-4504-AD1C-D9808765B01AQ24186746-6224A9A9-ED09-4DE3-91B1-487C57398B0CQ26748766-A710E7C5-99E3-4FAE-A998-8EB3B133EEB2Q26782993-2FD1FB2B-00F8-479B-A420-524D777B850BQ26799619-3A90C585-0FE0-472E-9E57-EE4602C94E46Q27028050-1DE155EB-B365-4705-A67E-D713D03C347BQ27305254-33FA7558-4669-4151-A7D2-520DC692CF02Q28817259-7AA925DC-75B2-42B2-8946-58F0E7B24D64Q30361531-934247E2-5EA6-473B-8B42-FDEB10474531Q30373328-D7E3591B-D5A2-4FBF-98E6-31A7856023B3Q30395004-66B48EAD-05B6-4BA8-97DC-4E5EB95824BFQ30651146-F506D0E6-8BA7-4BA7-8103-2FF207E4D9B1Q30679421-DA1D8D17-C216-4B6A-93F9-8C9F96E63F2CQ33785739-FF959441-EE86-4889-A704-A5F3102E1B25Q34198001-90F1B877-C05E-445E-A42E-B9997B13F980Q34445122-7AE7F317-C18B-4A64-8CA7-F9AF926FC78AQ35028372-5CD73477-E411-4B40-B58B-7B4AF116FA76Q35089417-07F53637-363B-450D-9884-DA1311B1C8F9Q35179047-15A455B2-597C-4F4C-8A94-7270CA19ABFDQ35241848-2A2C3C19-D9A2-4768-80EC-3C42BF17A3A5Q35580361-6BCB17CB-FAA9-422E-9481-33E3F10B48C5Q35633903-FD9D0F9D-B429-48D4-A9E2-06B02A3DDFC8Q36002723-AD6BE2C4-DD77-4D85-9504-F35539D7AF8FQ36273782-563C4C30-5E83-4AB9-88A7-3C902F93BF3EQ36498659-265A7068-399A-47FD-9FAD-97E4B3F69E15Q36733346-473468C5-F3A5-4EF8-BEC4-042C705A68DEQ36760914-B33C08B6-E2B1-48B9-A285-581F8176E95DQ36830164-925338E0-F2D2-4165-B3C2-3531AA6DDBE8Q37133173-C9674723-41ED-495D-9836-466D39A7485DQ37249086-F8B25493-F2CA-4CBC-A67F-30AA36C1678BQ37279054-C090B9C0-5C70-4DCF-893D-3351453C1A56Q37676446-C2AA8FB8-9A03-4C1E-812E-68E151AEEDD2Q37718994-95D2C4C9-1AD1-4D24-B928-E8A5CF0FB356Q38192667-02F53229-A750-4FEA-863B-1EC21D49DE15Q38207705-90BE4FDD-227C-4044-A770-B65AE52B4ADDQ38737919-1A14B8BC-7127-499F-8FD4-5AC8EF56346EQ38817194-F98C529B-15A0-4A41-B775-E20EDF44F82AQ38838307-00D7AD77-0C9F-4FF0-9F67-8CBB95EBDB8CQ38848607-0DC704DE-F747-4383-B79F-065E4F8216F5
P2860
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Antidepressant effects of keta ...... t-acting novel antidepressants
@ast
Antidepressant effects of keta ...... t-acting novel antidepressants
@en
Antidepressant effects of keta ...... t-acting novel antidepressants
@en-gb
Antidepressant effects of keta ...... t-acting novel antidepressants
@nl
type
label
Antidepressant effects of keta ...... t-acting novel antidepressants
@ast
Antidepressant effects of keta ...... t-acting novel antidepressants
@en
Antidepressant effects of keta ...... t-acting novel antidepressants
@en-gb
Antidepressant effects of keta ...... t-acting novel antidepressants
@nl
prefLabel
Antidepressant effects of keta ...... t-acting novel antidepressants
@ast
Antidepressant effects of keta ...... t-acting novel antidepressants
@en
Antidepressant effects of keta ...... t-acting novel antidepressants
@en-gb
Antidepressant effects of keta ...... t-acting novel antidepressants
@nl
P2860
P3181
P356
P1476
Antidepressant effects of keta ...... t-acting novel antidepressants
@en
P2093
Irwin Lucki
P2860
P3181
P356
10.3389/FPHAR.2013.00161
P407
P577
2013-12-27T00:00:00Z